CytomX Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.44 -0.14 (-2.51%) USD | NASDAQ | Feb 24, 16:00

5.45 +0.01 (+0.18%) After-Hours: 05:12

View EPS Basic from Tax Loss Carryforward (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--